This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Bristol-Myers Squibb Compnay, Syngene International Limited, Other. Active years: 2014-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Diego, CA (US) (2014)
- Plainsboro, NJ (US) (2018)
- North Wales, PA (US) (2022)
Company Filing History:
3 out of 3,742 
1 out of 7 
1 out of 834,513 Years Active: 2014-2025
Title: The Innovative Contributions of Carlos A Guerrero
Introduction
Carlos A Guerrero is a notable inventor based in North Wales, PA, with a focus on developing innovative processes and compounds. He holds three patents that highlight his contributions to the field of chemistry and pharmaceuticals. His work has significant implications, particularly in the development of anti-cancer agents.
Latest Patents
One of his latest patents is related to a synthetic process for preparing compounds, including a compound of Formula (I). This invention is useful as key intermediates in the preparation of compounds that exhibit RORγt antagonist properties. Another significant patent involves an improved process for making a compound B, which can be utilized to create tubulysin analogs. These analogs are particularly valuable as anti-cancer agents, especially when used in antibody-drug conjugates.
Career Highlights
Throughout his career, Carlos has worked with prominent companies, including Bristol-Myers Squibb Company. His experience in the pharmaceutical industry has allowed him to contribute to groundbreaking research and development efforts.
Collaborations
Carlos has collaborated with talented individuals such as Jason J Zhu and Ryan Shenvi. These partnerships have fostered innovation and have been instrumental in advancing his research.
Conclusion
Carlos A Guerrero's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect his commitment to developing effective solutions for critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile